2025-07-25 - Analysis Report
Okay, here's an analysis of Natera Inc. (NTRA) based on the information you provided.  The report is in English, includes key figures, and then offers analysis and interpretations.

**Natera Inc. (NTRA) Analysis**

Natera Inc. (NTRA) is a diagnostics company specializing in cell-free DNA testing for reproductive health, oncology, and organ health.

**1. Performance vs. S&P 500 (VOO)**

*   **Cumulative Return (NTRA):** 118.11%
*   **Cumulative Return (VOO):** 99.18%
*   **Absolute Divergence:** 20.3 (NTRA outperformed VOO by 20.3 percentage points)
*   **Relative Divergence:** 8.9 (This indicates NTRA's outperformance, while positive, is relatively low compared to its historical divergence range.)

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD   | Alpha  | Beta  | Cap(B) |
| ---------- | ------ | ----- | ------ | ----- | ------ |
| 2015-2017  | -6.0%  | 62.4% | -31.0% | 0.0  | 1.2    |
| 2016-2018  | 29.0%  | 80.1% | 11.0%  | 0.0  | 1.9    |
| 2017-2019  | 159.0% | 80.1% | 130.0% | 1.2  | 4.6    |
| 2018-2020  | 530.0% | 80.1% | 510.0% | 0.3  | 13.6   |
| 2019-2021  | 355.0% | 62.9% | 307.0% | 0.2  | 12.8   |
| 2020-2022  | -119.0% | 62.9% | -121.0% | 0.2  | 5.5    |
| 2021-2023  | -482.0% | 69.9% | -500.0% | 1.1  | 8.6    |
| 2022-2024  | -75.0%  | 70.6% | -100.0% | 1.2  | 21.6   |
| 2023-2025  | 67.0%  | 74.8% | 16.0%  | 0.8  | 19.3   |

**Analysis:**

*   **CAGR:** The Compounded Annual Growth Rate shows significant volatility across different periods, with substantial positive growth in some periods (e.g., 2018-2020, 2019-2021) and severe negative growth in others (e.g., 2021-2023).
*   **MDD:** The Maximum Drawdown is consistently high, indicating significant potential for losses during downturns.
*   **Alpha:** The Alpha values vary widely, reflecting periods of significant outperformance (high positive Alpha) and underperformance (high negative Alpha) relative to the market.
*   **Beta:** The Beta values indicate the stock's volatility relative to the market. Values around 1 (e.g., 2017-2019, 2021-2023, 2022-2024) suggest NTRA moves similarly to the market, while values less than 1 suggest less volatility.
*   **Cap:** Market capitalization shows fluctuations, reflecting investor sentiment and company performance over time.

**2. Recent Price Action**

*   **Current Price:** $141.07
*   **Previous Close:** $137.82
*   **Price Change:** +$3.25 (+2.35%)
*   **5-day Moving Average:** $139.67
*   **20-day Moving Average:** $154.52
*   **60-day Moving Average:** $158.03

**Analysis:**

*   The stock has shown a recent upward movement as price change is positive. The current price is above the 5-day moving average but below both the 20-day and 60-day moving averages. This suggests a potential short-term upward trend but longer-term resistance.
*   The recent positive price change indicates a potentially positive signal.

**3. Technical Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.3274 (Low Risk)
*   **RSI:** 24.39 (Oversold)
*   **PPO:** -1.42
*   **Hybrid Signal:** cash_70%_Sell 0.2% of holdings (1 shares - Caution - MRI:0.33) (Cash Ratio: 70% on 2025-07-03)
*   **Recent (20-day) Relative Divergence Change:** -0.9 (Short-term decrease)
*   **Expected Return:** 188.7% (Long-term, relative to S&P 500)

**Analysis:**

*   The MRI suggests a low level of market risk.
*   The RSI indicates the stock is currently oversold, which could signal a potential buying opportunity.
*   The PPO is negative, indicating the price is below its moving average, suggesting a potential downward trend.
*   Hybrid Signal advice 70% Cash Ratio, which is very conservative.
*   The recent decrease in relative divergence suggests that the stock's performance is weakening compared to the S&P 500.
*   Despite the recent weakness, the expected return is very high, suggesting that analysts anticipate strong long-term growth relative to the market.
*   The price change of 2.35 is significant in the short term, potentially due to a recent issue.

**4. Recent News & Significant Events**

*   **[2025-07-24]:** Major business developments, regulatory changes, or market events.
*   **[2025-07-21]:** Analyst discussions on recent performance and outlook.
*   **[2025-07-25]:** Notable stock volatility influenced by recent news.
*   **[2025-07-22]:** Market experts highlight risks and opportunities.

**Analysis:**

The news headlines suggest recent volatility and significant developments surrounding NTRA. Investors should monitor news and company announcements closely.

**5. Recent Earnings Analysis**

| Date       | EPS    | Revenue   |
| ---------- | ------ | --------- |
| 2025-05-09 | -0.50  | $0.50 B   |
| 2024-11-12 | -0.26  | $0.44 B   |
| 2024-08-09 | -0.30  | $0.41 B   |
| 2024-05-10 | -0.56  | $0.37 B   |
| 2025-05-09 | -0.56  | $0.37 B   |

**Analysis:**

*   The company has consistently reported negative Earnings Per Share (EPS), indicating a lack of profitability.
*   Revenue has been increasing, suggesting growth in sales. However, the increased revenue has not translated into profitability.

**6. Financial Information**

**Revenue and Profitability**

| Quarter    | Revenue   | Profit Margin |
| ---------- | --------- | ------------- |
| 2025-03-31 | $0.50B    | 63.12%        |
| 2024-12-31 | $0.48B    | 62.94%        |
| 2024-09-30 | $0.44B    | 61.79%        |
| 2024-06-30 | $0.41B    | 58.83%        |
| 2024-03-31 | $0.37B    | 56.72%        |

**Capital and Profitability**

| Quarter    | Equity    | ROE      |
| ---------- | --------- | -------- |
| 2025-03-31 | $1.24B    | -5.40%   |
| 2024-12-31 | $1.20B    | -4.50%   |
| 2024-09-30 | $0.88B    | -3.60%   |
| 2024-06-30 | $0.84B    | -4.48%   |
| 2024-03-31 | $0.79B    | -8.51%   |

**Analysis:**

*   **Revenue and Profitability:** Revenue is consistently increasing, and the profit margin is relatively high and stable, suggesting efficient operations.
*   **Capital and Profitability:** Equity is growing, but Return on Equity (ROE) is negative, indicating that the company is not generating profits from its equity.

**7. Overall Analysis**

Natera Inc. (NTRA) shows a mixed financial picture. While it has demonstrated strong revenue growth and a high profit margin, it has consistently reported negative earnings and negative ROE, indicating a struggle with overall profitability. The stock's historical performance has been volatile, with periods of significant outperformance and underperformance relative to the S&P 500. The recent price action suggests a potential short-term upward trend. However, the high long-term expected return contrasts with the negative short-term indicators.

**Investment Recommendation:**

Given the conflicting signals – strong revenue growth, high expected return, but negative earnings and high volatility – a cautious approach is warranted. Investors should closely monitor the company's progress toward profitability and keep abreast of the latest news and developments.
